Incepta Pharmaceuticals – Quality Generics from Bangladesh

Incepta Pharmaceuticals

Country: Bangladesh

Incepta Pharmaceuticals Ltd. is a Bangladeshi pharmaceutical company founded in 1999 and headquartered in Dhaka. It is privately held and led by Abdul Muktadir, its chairman and managing director.

Incepta makes a broad range of generic medicines, including cancer drugs, as well as biotech products — epoetin, granulocyte colony-stimulating factor (G-CSF) and adalimumab — and human vaccines. In 2015 it was among the first to launch a generic of sofosbuvir for hepatitis C in Bangladesh.

Production is based at two sites near Dhaka, in Zirabo (Savar) and Dhamrai. The Zirabo site holds a UK MHRA GMP certificate for tablets and capsules, and in 2025 a unit at Dhamrai was inspected by the WHO prequalification programme. According to the company, Incepta exports to more than 100 countries.

Unifarm carries Incepta's oncology medicines: Palbocent 125 (palbociclib), Crizocent 250 (crizotinib) and Osicent (osimertinib).

Official manufacturer website
Incepta Pharmaceuticals

List of medicines by manufacturer Incepta Pharmaceuticals

-14%
Palbocent 125
View
Incepta Pharmaceuticals
125 mg 21 capsule
8046₴ 9387₴
-6%
Crizocent 250
View
Incepta Pharmaceuticals
250 mg 60 capsules
15377₴ 16316₴
-7%
Osicent
View
Incepta Pharmaceuticals
80 mg 30 tablets
12516₴ 13410₴
✅ All products loaded (3)

Contact us

Choose a convenient way to contact

We work daily from 9:00 to 20:00